These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19465957)

  • 1. Capecitabine-induced acute myeloid leukaemia.
    Tansley S; Gibbons S
    N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
    Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
    [No Abstract]   [Full Text] [Related]  

  • 3. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.
    Aksoy S; Karaca B; Dinçer M; Yalçin S
    Ann Pharmacother; 2005 Mar; 39(3):573-4. PubMed ID: 15701780
    [No Abstract]   [Full Text] [Related]  

  • 4. Dermatomyositis associated with capecitabine in the setting of malignancy.
    Chen FW; Zhou X; Egbert BM; Swetter SM; Sarin KY
    J Am Acad Dermatol; 2014 Feb; 70(2):e47-8. PubMed ID: 24438983
    [No Abstract]   [Full Text] [Related]  

  • 5. Capecitabine-associated coronary vasospasm: a case report.
    Papadopoulos CA; Wilson H
    Emerg Med J; 2008 May; 25(5):307-9. PubMed ID: 18434478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute coronary syndrome induced by capecitabine therapy.
    Wijesinghe N; Thompson PI; McAlister H
    Heart Lung Circ; 2006 Oct; 15(5):337-9. PubMed ID: 16697705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypertriglyceridaemia associated with the use of capecitabine.
    Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
    Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
    [No Abstract]   [Full Text] [Related]  

  • 8. Capecitabine induced colitis.
    Maggo G; Grover SC; Grin A
    Pathol Res Pract; 2014 Sep; 210(9):606-8. PubMed ID: 24947412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.
    Saadati H; Saif MW
    JOP; 2008 May; 9(3):354-6. PubMed ID: 18469454
    [No Abstract]   [Full Text] [Related]  

  • 10. Capecitabine-induced cerebellar toxicity.
    Renouf D; Gill S
    Clin Colorectal Cancer; 2006 May; 6(1):70-1. PubMed ID: 16796795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
    Serrão VV; Feio AB
    Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
    [No Abstract]   [Full Text] [Related]  

  • 12. [Suspected dihydropyrimidine dehydrogenase deficiency in a patient receiving capecitabine as adjuvant chemotherapy after colon resection].
    Nagai K; Okuda Y; Ohara Y; Yamamoto M
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):127-9. PubMed ID: 25596695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
    Dalmau J; Roé E; Puig L; Alomar A
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapy-related acute promyelocytic leukemia after chemoradiotherapy with capecitabine for rectal adenocarcinoma.
    Rashidi A; Man L; Howard JR; Atienza D; Fisher SI
    Leuk Lymphoma; 2014 Mar; 55(3):683-4. PubMed ID: 23837492
    [No Abstract]   [Full Text] [Related]  

  • 15. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
    Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
    [No Abstract]   [Full Text] [Related]  

  • 16. Capecitabine-induced terminal ileitis.
    Al-Gahmi AM; Kerr IG; Zekri JM; Zagnoon AA
    Ann Saudi Med; 2012; 32(6):661-2. PubMed ID: 23396034
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
    Ghosal N; Misra V
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
    [No Abstract]   [Full Text] [Related]  

  • 18. [The prevention of diarrhea while under capecitabine therapy].
    Grouls V
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1750. PubMed ID: 18696410
    [No Abstract]   [Full Text] [Related]  

  • 19. Dramatic response of recalcitrant warts as a side effect of colorectal cancer treatment with oral capecitabine.
    Bel B; Lorton MH; Darut-Jouve A; Vabres P
    Eur J Dermatol; 2011; 21(5):789-90. PubMed ID: 21700544
    [No Abstract]   [Full Text] [Related]  

  • 20. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
    Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ
    Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.